The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis
Open accessAbstract
Ovarian cancer is the most lethal gynecological malignancy. It is usually diagnosed at a late stage, with a 5-yr survival rate of <30%. The majority of ovarian cancer cases are diagnosed after tumors have widely spread within the peritoneal cavity, limiting the effectiveness of debulking surgery and chemotherapy. Owing to a substantially lower survival rate at late stages of disease than at earlier stages, the major cause of ovarian cancer deaths is believed to be therapy-resistant metastasis. Although metastasis plays a crucial role in promoting ovarian tumor progression and decreasing patient survival rates, the underlying mechanisms of ovarian cancer spread have yet to be thoroughly explored. For many years, researchers have believed that ovarian cancer metastasizes via a passive mechanism by which ovarian cancer cells are shed from the primary tumor and carried by the physiological movement of peritoneal fluid to the peritoneum and omentum. However, the recent discovery of hematogenous metastasis of ovarian cancer to the omentum via circulating tumor cells instigated rethinking of the mode of ovarian cancer metastasis and the importance of the “seed-and-soil” hypothesis for ovarian cancer metastasis. In this review we discuss the possible mechanisms by which ovarian cancer cells metastasize from the primary tumor to the omentum, the cross-talk signaling events between ovarian cancer cells and various stromal cells that play crucial roles in ovarian cancer metastasis, and the possible clinical implications of these findings in the management of this deadly, highly metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Targeting CAFs for cancer treatment is believed to have two benefits: 1) the ongoing function of CAFs is critical to the growth of nearby neoplastic cells, and 2) stromal cells are more genetically stable than carcinoma cells, which can accumulate adaptive mutations during the course of therapy to acquire drug resista…”
BackgroundMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Cellular Motility Driven by Assembly and Disassembly of Actin Filaments
Pollard, T. D., & Borisy, G. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00120-x · Cited by 4,195
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Burger, R. A., Brady, M. F., Bookman, M. A., Fleming, G. F., Monk, B. J., Huang, H., Mannel, R. S., Homesley, H. D., Fowler, J., Greer, B. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104390 · Cited by 2,404
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · cited 1×
“On the other hand, CXCL12 in ascitic fluid binds to its receptor, CXCR4, on ovarian cancer cells, increasing the expression of 1-integrin and the migratory potential of epithelial ovarian cancer cells (7).”
BackgroundAdipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Perren, T. J., Swart, A. M., Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Kurzeder, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103799 · Cited by 2,172
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1477 · Cited by 1,765
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672
Forming functional fat: a growing understanding of adipocyte differentiation
Cristancho, A. G., & Lazar, M. A. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3198 · Cited by 1,382
The biology of ovarian cancer: new opportunities for translation
Bast, R. C., Hennessy, B., & Mills, G. B. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2644 · Cited by 1,358
The role of angiogenesis in tumor growth.
Folkman, J. (1992) · PubMed · Cited by 1,259
Goel, H. L., & Mercurio, A. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3627 · Cited by 1,253
Cell migration: Rho GTPases lead the way
Raftopoulou, M., & Hall, A. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2003.06.003 · Cited by 1,235
Monocyte chemoattractant protein 1 in obesity and insulin resistance
Sartipy, P., & Loskutoff, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133870100 · Cited by 1,201
Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion
Dirat, B., Bochet, L., Dabek, M., Daviaud, D., Dauvillier, S., Majed, B., Wang, Y. Y., Meulle, A., Salles, B., Le Gonidec, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3323 · Cited by 1,134
TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENT
Tlsty, T. D., & Coussens, L. M. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100224 · Cited by 987
Sunitinib: From Rational Design to Clinical Efficacy
Chow, L. Q. M., & Eckhardt, S. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.3602 · Cited by 883
Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type
Orimo, A., & Weinberg, R. A. (2006) · Cell Cycle · doi:10.4161/cc.5.15.3112 · Cited by 799
Adipose tissue and adipocytes support tumorigenesis and metastasis
Nieman, K. M., Romero, I. L., Van Houten, B., & Lengyel, E. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.02.010 · Cited by 749
The many faces of actin: matching assembly factors with cellular structures
Chhabra, E. S., & Higgs, H. N. (2007) · Nature Cell Biology · doi:10.1038/ncb1007-1110 · Cited by 744
Wedge, S. R., Kendrew, J., Hennequin, L. F., Valentine, P. J., Barry, S. T., Brave, S. R., Smith, N. R., James, N. H., Dukes, M., Curwen, J. O., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4409 · Cited by 714
Identification of fibroblast heterogeneity in the tumor microenvironment
Sugimoto, H., Mundel, T. M., Kieran, M. W., & Kalluri, R. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3354 · Cited by 699
Regulation of cancer cell motility through actin reorganization
Yamazaki, D., Kurisu, S., & Takenawa, T. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00062.x · Cited by 613
Calcium in tumour metastasis: new roles for known actors
Prevarskaya, N., Skryma, R., & Shuba, Y. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3105 · Cited by 605
Mechanisms of Myofibroblast Activity and Phenotypic Modulation
Serini, G., & Gabbiani, G. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4543 · Cited by 600
Tumor interactions with the vasculature: angiogenesis and tumor metastasis
Blood, C. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(90)90014-r · Cited by 593
Liu, J. F., Barry, W. T., Birrer, M., Lee, J.-M., Buckanovich, R. J., Fleming, G. F., Rimel, B., Buss, M. K., Nattam, S., Hurteau, J., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70391-2 · Cited by 585
Therapeutic targeting of the tumor microenvironment
Joyce, J. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.024 · Cited by 582
The actin cytoskeleton in cancer cell motility
Olson, M. F., & Sahai, E. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9174-2 · Cited by 572
Buckanovich, R. J., Facciabene, A., Kim, S., Benencia, F., Sasaroli, D., Balint, K., Katsaros, D., O'Brien-Jenkins, A., Gimotty, P. A., & Coukos, G. (2008) · Nature Medicine · doi:10.1038/nm1699 · Cited by 546
Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
Swartz, M. A., Iida, N., Roberts, E. W., Sangaletti, S., Wong, M. H., Yull, F. E., Coussens, L. M., & DeClerck, Y. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0122 · Cited by 542
Ovarian Cancer Metastasis: Integrating insights from disparate model organisms
Naora, H., & Montell, D. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1611 · Cited by 538
Mechanisms of transcoelomic metastasis in ovarian cancer
Tan, D. S., Agarwal, R., & Kaye, S. B. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70939-1 · Cited by 520
Ovarian carcinoma diagnosis: Results of a national ovarian cancer survey
Goff, B. A., Mandel, L., Muntz, H. G., & Melancon, C. H. (2000) · Cancer · doi:10.1002/1097-0142(20001115)89:10<2068::aid-cncr6>3.0.co;2-z · Cited by 502
Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction
Friesel, R. E., & Maciag, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7542215 · Cited by 455
Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
Brooks, A. N., Kilgour, E., & Smith, P. D. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0699 · Cited by 446
Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK
Hagemann, T., Wilson, J., Kulbe, H., Li, N. F., Leinster, D. A., Charles, K., Klemm, F., Pukrop, T., Binder, C., & Balkwill, F. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1197 · Cited by 434
Jin, G., & Wong, S. T. C. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.11.005 · Cited by 416
Self-citationYeung, T.-L., Leung, C. S., Wong, K.-K., Samimi, G., Thompson, M. S., Liu, J., Zaid, T. M., Ghosh, S., Birrer, M. J., & Mok, S. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0023 · Cited by 394
Self-citationRole of Vascular Endothelial Growth Factor in Ovarian Cancer
Mesiano, S., Ferrara, N., & Jaffe, R. B. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65669-6 · Cited by 392
Bellingan, G. J., Caldwell, H., Howie, S. E., Dransfield, I., & Haslett, C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2577 · Cited by 378
Kraft, A., Weindel, K., Ochs, A., Marth, C., Zmija, J., Schumacher, P., Unger, C., Marm�, D., & Gastl, G. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990101)85:1<178::aid-cncr25>3.0.co;2-7 · Cited by 372
Kenny, H. A., Kaur, S., Coussens, L. M., & Lengyel, E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33775 · Cited by 370
Ascitic fluid analysis in malignancy-related ascites
Runyon, B. A., Hoefs, J. C., & Morgan, T. R. (1988) · Hepatology · doi:10.1002/hep.1840080521 · Cited by 361
Huang, S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.15.1134 · Cited by 349
Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?
Micke, P., & tman, A. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.07.977 · Cited by 344
Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer
du Bois, A., Floquet, A., Kim, J.-W., Rau, J., del Campo, J. M., Friedlander, M., Pignata, S., Fujiwara, K., Vergote, I., Colombo, N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.7348 · Cited by 328
Belotti, D., Paganoni, P., Manenti, L., Garofalo, A., Marchini, S., Taraboletti, G., & Giavazzi, R. (2003) · PubMed · Cited by 318
Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival
Cieslewicz, M., Tang, J., Yu, J. L., Cao, H., Zavaljevski, M., Motoyama, K., Lieber, A., Raines, E. W., & Pun, S. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312197110 · Cited by 314
Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
Pradeep, S., Kim, S. W., Wu, S. Y., Nishimura, M., Chaluvally-Raghavan, P., Miyake, T., Pecot, C. V., Kim, S.-J., Choi, H. J., Bischoff, F. Z., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.002 · Cited by 311
Mesothelial Cells Promote Early Ovarian Cancer Metastasis through Fibronectin Secretion
Kenny, H. A., Chiang, C.-Y., White, E. A., Schryver, E. M., Habis, M., Romero, I. L., Ladanyi, A., Penicka, C. V., George, J., Matlin, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74778 · Cited by 303
Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts.
Tarin, D., Price, J. E., Kettlewell, M. G. W., Souter, R. G., Ac, V., & Crossley, B. (1984) · PubMed · Cited by 303
Tropomyosin isoforms: divining rods for actin cytoskeleton function
Gunning, P. W., Schevzov, G., Kee, A. J., & Hardeman, E. C. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.04.007 · Cited by 302
Calcium Gradients Underlying Polarization and Chemotaxis of Eosinophils
Brundage, R. A., Fogarty, K. E., Tuft, R. A., & Fay, F. S. (1991) · Science · doi:10.1126/science.1948048 · Cited by 294
Nagy, J. A., Masse, E., Herzberg, K. T., Meyers, M., Yeo, K. T., Yeo, T.-K., Sioussat, T. M., & Dvorak, H. F. (1995) · PubMed · Cited by 281
Matsuo, Y., Ochi, N., Sawai, H., Yasuda, A., Takahashi, H., Funahashi, H., Takeyama, H., Tong, Z., & Guha, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24040 · Cited by 279
Berchuck, A., Iversen, E. S., Lancaster, J. M., Pittman, J., Luo, J., Lee, P., Murphy, S., Dressman, H. K., Febbo, P. G., West, M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2398 · Cited by 266
Lysophosphatidic acid is a bioactive mediator in ovarian cancer
Fang, X. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00179-8 · Cited by 264
Differential Gene Expression in Ovarian Carcinoma
Hibbs, K., Skubitz, K. M., Pambuccian, S. E., Casey, R. C., Burleson, K. M., Oegema, T. R., Thiele, J. J., Grindle, S. M., Bliss, R. L., & Skubitz, A. P. N. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63306-8 · Cited by 256
Inouye, K. E., Shi, H., Howard, J. K., Daly, C. H., Lord, G. M., Rollins, B. J., & Flier, J. S. (2007) · Diabetes · doi:10.2337/db07-0425 · Cited by 252 · cited 1×
“In addition, several adipokines secreted by adipose tissue, including tumor necrosis factor- , IL-6, IL-8, and monocyte chemoattractant protein-1, have been implicated in tumor progression (65, 77, 134).”
BackgroundKenny, H. A., Krausz, T., Yamada, S. D., & Lengyel, E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22874 · Cited by 243
Fishman, D. A., Stack, S., Ellerbroek, S. M., & Liu, Y. (2022) · PubMed · doi:10.7274/24738663 · Cited by 241
Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread
Carmignani, C. P., Sugarbaker, T. A., Bromley, C. M., & Sugarbaker, P. H. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023791229361 · Cited by 232
Force transmission in migrating cells
Fournier, M. F., Sauser, R., Ambrosi, D., Meister, J.-J., & Verkhovsky, A. B. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200906139 · Cited by 231
Manabe, Y., Toda, S., Miyazaki, K., & Sugihara, H. (2003) · The Journal of Pathology · doi:10.1002/path.1430 · Cited by 230
A Novel Platform for Detection of CK+ and CK− CTCs
Pecot, C. V., Bischoff, F. Z., Mayer, J. A., Wong, K. L., Pham, T., Bottsford-Miller, J., Stone, R. L., Lin, Y. G., Jaladurgam, P., Roh, J. W., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0215 · Cited by 217
Crawling Toward a Unified Model of Cell Motility: Spatial and Temporal Regulation of Actin Dynamics
Rafelski, S. M., & Theriot, J. A. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073844 · Cited by 211
Macrophages Mediate Inflammation-Enhanced Metastasis of Ovarian Tumors in Mice
Robinson-Smith, T. M., Isaacsohn, I., Mercer, C. A., Zhou, M., Van Rooijen, N., Husseinzadeh, N., McFarland-Mancini, M. M., & Drew, A. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4375 · Cited by 199
Gerber, S. A., Rybalko, V. Y., Bigelow, C. E., Lugade, A. A., Foster, T. H., Frelinger, J. G., & Lord, E. M. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051222 · Cited by 197
Predicting biomarkers for ovarian cancer using gene-expression microarrays
Adib, T. R., Henderson, S., Perrett, C., Hewitt, D., Bourmpoulia, D., Ledermann, J., & Boshoff, C. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601603 · Cited by 193
Mueller, L., Goumas, F. A., Affeldt, M., Sandtner, S., Gehling, U. M., Brilloff, S., Walter, J., Karnatz, N., Lamszus, K., Rogiers, X., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060661 · Cited by 190
Andarawewa, K. L., Motrescu, E. R., Chenard, M.-P., Gansmuller, A., Stoll, I., Tomasetto, C., & Rio, M.-C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1231 · Cited by 187
Schauer, I. G., Sood, A. K., Mok, S. C., & Liu, J. (2011) · Neoplasia · doi:10.1593/neo.101720 · Cited by 186
Self-citationPazopanib: Clinical development of a potent anti-angiogenic drug
Schutz, F. A. B., Choueiri, T. K., & Sternberg, C. N. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.02.012 · Cited by 183
E-cadherin expression in human epithelial ovarian cancer and normal ovary
Sundfeldt, K., Piontkewitz, Y., Ivarsson, K., Nilsson, O., Hellberg, P., Brännströ:m, M., Janson, P.-O., Enerbäck, S., & Hedin, L. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970620)74:3<275::aid-ijc7>3.0.co;2-w · Cited by 180
Patterns of elevated free calcium and calmodulin activation in living cells
Hahn, K., DeBiasio, R., & Taylor, D. L. (1992) · Nature · doi:10.1038/359736a0 · Cited by 179
Invadopodia and podosomes in tumor invasion
Yamaguchi, H., Pixley, F., & Condeelis, J. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.10.004 · Cited by 174
Choi, H., Sheng, J., Gao, D., Li, F., Durrans, A., Ryu, S., Lee, S. B., Narula, N., Rafii, S., Elemento, O., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.040 · Cited by 166
Self-citationBirrer, M., Johnson, M. E., Hao, K., Wong, K. K., Park, D., Bell, A., Welch, W., Berkowitz, R., & Mok, S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0795 · Cited by 165
Self-citationSCHOPPMANN, S. F., Fenzl, A., Nagy, K., UNGER, S., Bayer, G., Geleff, S., Gnant, M., Horvat, R., Jakesz, R., & Birner, P. (2006) · Surgery · doi:10.1016/j.surg.2005.12.008 · Cited by 155
Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
Pustilnik, T. B., Estrella, V. C., Wiener, J. R., Mao, M., Eder, A. M., Watt, M. A. V., Bast, R. C., & Mills, G. B. (1999) · PubMed · Cited by 153
Clark, R., Krishnan, V., Schoof, M., Rodriguez, I., Theriault, B. R., Chekmareva, M. A., & Rinker-Schaeffer, C. W. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.04.023 · Cited by 151
Zhang, L., Yang, N., Conejo Garcia, J.-R., Mohamed, A., Benencia, F., Rubin, S. C., Allman, D., & Coukos, G. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64505-1 · Cited by 151
Xu, L., Yoneda, J., Herrera, C., Wood, J., Killion, J. J., & Fidler, I. J. (2000) · International Journal of Oncology · doi:10.3892/ijo.16.3.445 · Cited by 148
VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma
Chen, H., Ye, D.-F., Xie, X., Chen, B., & Lü, W. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.05.056 · Cited by 146
Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice.
Hagiwara, A., Takahashi, T., Sawai, K., Taniguchi, H., Shimotsuma, M., Okano, S., Sakakura, C., Tsujimoto, H., Osaki, K., & Sasaki, S. (1993) · PubMed · Cited by 145
Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
Freedman, R. S., Deavers, M. T., Liu, J., & Wang, E. (2004) · Journal of Translational Medicine · doi:10.1186/1479-5876-2-23 · Cited by 144
Leung, C. S., Yeung, T.-L., Yip, K., Pradeep, S., Balasubramanian, L., Liu, J., Wong, K., Mangala, L. S., Armaiz-Peña, G. N., Lopez‐Berestein, G., et al. (2014) · Nature Communications · doi:10.1038/ncomms6092 · Cited by 139
Self-citationOvarian cancer: Can we make the clinical diagnosis earlier?
Smith, L. H., Morris, C. R., Yasmeen, S., Parikh‐Patel, A., Cress, R. D., & Romano, P. S. (2005) · Cancer · doi:10.1002/cncr.21310 · Cited by 138
Sundfeldt, K. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00068-6 · Cited by 135
Folkman, J., & Ingber, D. E. (1992) · PubMed · Cited by 135
Biagi, J. J., Oza, A. M., Chalchal, H. I., Grimshaw, R. N., Ellard, S. L., Lee, U., Hirte, H. W., Sederias, J., Ivy, S. P., & Eisenhauer, E. A. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq357 · Cited by 134
Nowicka, A., Marini, F. C., Solley, T. N., Elizondo, P. B., Zhang, Y., Sharp, H. J., Broaddus, R. R., Kolonin, M. G., Mok, S. C., Thompson, M. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081859 · Cited by 126
Self-citationMcGrail, D. J., Kieu, Q. M. N., & Dawson, M. (2014) · Journal of Cell Science · doi:10.1242/jcs.144378 · Cited by 124
Ströbel, T., Swanson, L., & Cannistra, S. A. (1997) · PubMed · Cited by 123
Ohira, S., Sasaki, M., Harada, K., Sato, Y., Zen, Y., Isse, K., Kozaka, K., Ishikawa, A., Oda, K., Nimura, Y., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050204 · Cited by 120
Unraveling the Obesity and Breast Cancer Links: A Role for Cancer-Associated Adipocytes?
Dirat, B., Bochet, L., Escourrou, G., Valet, P., & Muller, C. (2010) · Endocrine development · doi:10.1159/000316896 · Cited by 116
Huang, M., Li, Y., Zhang, H., & Nan, F. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-80 · Cited by 116
Gene Expression Patterns That Characterize Advanced Stage Serous Ovarian Cancers
Lancaster, J. M., Dressman, H. K., Whitaker, R. S., Havrilesky, L. J., Gray, J., Marks, J. R., Nevins, J. R., & Berchuck, A. (2003) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2003.07.004 · Cited by 108
Haverty, P. M., Hon, L., Kaminker, J. S., Chant, J., & Zhang, Z. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-21 · Cited by 105
Prostate cancer cell growth is modulated by adipocyte‐cancer cell interaction
Tokuda, Y., Satoh, Y., Fujiyama, C., Toda, S., Sugihara, H., & Masaki, Z. (2003) · British Journal of Urology · doi:10.1046/j.1464-410x.2003.04218.x · Cited by 99
Kenny, H. A., Dogan, S., Zillhardt, M., Mitra, A. K., Yamada, S. D., Krausz, T. N., & Lengyel, E. R. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-98094-2_16 · Cited by 96
Composition of the extracellular matrix of the peritoneum
Witz, C. (2001) · Journal of the Society for Gynecologic Investigation · doi:10.1016/s1071-5576(01)00122-8 · Cited by 96
FGF18 as a prognostic and therapeutic biomarker in ovarian cancer
Wei, W., Mok, S. C., Oliva, E., Kim, S., Mohapatra, G., & Birrer, M. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70625 · Cited by 95
Self-citationPhillips, K. G., Velasco, C. R., Li, J., Kolatkar, A. R., Luttgen, M. S., Bethel, K. J., Duggan, B. D., Kühn, P., & McCarty, O. J. T. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00072 · Cited by 91
Daly, A. J., McIlreavey, L., & Irwin, C. R. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.08.012 · Cited by 87
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer
Tebbe, C., Chhina, J., Dar, S. A., Sarigiannis, K. A., Giri, S., Munkarah, A. R., & Rattan, R. (2014) · Oncotarget · doi:10.18632/oncotarget.2012 · Cited by 83
Wang, X., Deavers, M. T., Patenia, R. S., Bassett, R. L., Mueller, P., Ma, Q., Wang, E., & Freedman, R. S. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-30 · Cited by 83
Milky spots in the mouse omentum may play an important role in the origin of peritoneal macrophages
Wijffels, J. F. A. M., Hendrickx, R. J. B. M., Steenbergen, J. J. E., Eestermans, I. L., & Beelen, R. H. J. (1992) · Research in Immunology · doi:10.1016/s0923-2494(05)80072-0 · Cited by 83
Zaid, T., Yeung, T., Thompson, M. S., Leung, C. S., Harding, T. C., Co, N., Schmandt, R., Kwan, S.-Y., Rodriguez-Aguay, C., Lopez-Berestein, G., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2736 · Cited by 77
Self-citationStromal Compartment as a Survival Prognostic Factor in Advanced Ovarian Carcinoma
Labiche, A., Heutte, N., Herlin, P., Chasle, J., Gauduchon, P., & Elie, N. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181bda1cb · Cited by 73
Chi, J.-Y., Hsiao, Y., Li, C., Lo, Y.-C., Lin, Z., Hong, J., Liu, Y.-M., Han, X., Wang, S., Chen, B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4364 · Cited by 67
Baldwin, R. L., Tran, H., & Karlan, B. Y. (2003) · PubMed · Cited by 60
Pathology of the peritoneum: a review of selected topics.
Daya, D., & McCaughey, W. (1991) · PubMed · Cited by 59
Féki, A., Berardi, P., Bellingan, G. J., Major, A. L., Krause, K., Petignat, P., Zehra, R., Pervaiz, S., & Irminger‐Finger, I. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.12.003 · Cited by 59
Separation, cultivation and biological characteristics of oral carcinoma‐associated fibroblasts
Liu, Y., Hu, T., Shen, J., Li, S., Lin, J.-W., Xh, Z., Gao, Q. H., & Zhou, H. (2006) · Oral Diseases · doi:10.1111/j.1601-0825.2005.01207.x · Cited by 57
Yamada, S. D., Baldwin, R. L., & Karlan, B. Y. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5535 · Cited by 54
Campos, S. M., Penson, R. T., Matulonis, U. A., Horowitz, N. S., Whalen, C., Pereira, L., Tyburski, K., Roche, M. R., Szymonifka, J. D., & Berlin, S. T. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.07.126 · Cited by 51
Guerrero, J., Tobar, N., Cáceres, M., Espinoza, L., Escobar, P., Dotor, J., Smith, P. C., & Martı́nez, J. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0491-1 · Cited by 49
DrugMap Central: an on-line query and visualization tool to facilitate drug repositioning studies
Fu, C., Jin, G., Gao, J., Zhu, R., Ballesteros-villagrana, E., & Wong, S. T. C. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt279 · Cited by 44
Self-citationDrug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer
Banno, K., Iida, M., Yanokura, M., Irie, H., Masuda, K., Kobayashi, Y., Tominaga, E., & Aoki, D. (2015) · The Scientific World JOURNAL · doi:10.1155/2015/341362 · Cited by 43
Angiogenesis in the Bone Marrow of Patients with Breast Cancer
Chávez‐MacGregor, M., Avilés‐Salas, A., Green, D., Fuentes‐Alburo, A., Gómez-Ruíz, C., & Aguayo, Á. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2420 · Cited by 43
The influence of microvessel density on ovarian carcinogenesis
Stone, P. J. B., Goodheart, M. J., Rose, S. L., Smith, B. J., DeYoung, B. R., & Buller, R. E. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00367-6 · Cited by 41
Therapeutic Effects of Repurposed Therapies in Non-Small Cell Lung Cancer: What Is Old Is New Again
Saxena, A., Becker, D. J., Preeshagul, I. R., Lee, K. S., Katz, E., & Levy, B. P. (2015) · The Oncologist · doi:10.1634/theoncologist.2015-0064 · Cited by 37
Shimotsuma, M., Simpson-Morgan, M. W., Takahashi, T., & Hagiwara, A. (1992) · PubMed · Cited by 36
Haskill, S., Koren, H. S., Becker, S., Fowler, W. C., & Walton, L. A. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.116 · Cited by 33
Antiangiogenic agents in gynecological cancer: State of art and perspectives of clinical research
Gadducci, A., Lanfredini, N., & Sergiampietri, C. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.05.009 · Cited by 31
Ohira, S., Itatsu, K., Sasaki, M., Harada, K., Sato, Y., Zen, Y., Ishikawa, A., Oda, K., Nagasaka, T., Nimura, Y., et al. (2006) · Pathology International · doi:10.1111/j.1440-1827.2006.01982.x · Cited by 30
Piccirillo, S. G. M., Spiteri, I., Sottoriva, A., et al. (2013) · Cancer Research · doi:10.1158/1538-7445.am2013-5016 · Cited by 28
CAF reprogramming inhibits ovarian cancer progression
Yeung, T.-L., Leung, C. S., & Mok, S. C. (2014) · Cell Cycle · doi:10.4161/15384101.2014.988106 · Cited by 27
Self-citationThe potential of sunitinib as a therapy in ovarian cancer
Maggiore, U. L. R., Menada, M. V., Venturini, P. L., & Ferrero, S. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.841138 · Cited by 22
The Origin of Stroma Surrounding Epithelial Ovarian Cancer Cells
Akahane, T., Hirasawa, A., Tsuda, H., et al. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3182518533 · Cited by 13
Cited by
Breast Cancer Metastasis: Mechanisms and Therapeutic Implications
Park, M., Kim, D., Ko, S., Kim, A., Mo, K., & Yoon, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126806 · Cited by 406
The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer
Nowak, M., & Klink, M. (2020) · Cells · doi:10.3390/cells9051299 · Cited by 287
Motohara, T., Masuda, K., Morotti, M., Zheng, Y., El-Sahhar, S., Chong, K. Y., Wietek, N., Alsaadi, A., Carrami, E. M., Hu, Z., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0637-x · Cited by 218
Leung, C. S., Yeung, T.-L., Yip, K.-P., Wong, K.-K., Ho, S. Y., Mangala, L. S., Sood, A. K., Lopez-Berestein, G., Sheng, J., Wong, S. T. C., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95200 · Cited by 132
Self-citation
Metadata
- Authors
- Yeung, T.-L., Leung, C. S., Yip, K.-P., Au Yeung, C. L., Wong, S. T. C., & Mok, S. C.
- Venue
- American Journal of Physiology-Cell Physiology
- Publisher
- American Physiological Society
- Published
- 2015-10-01
- Volume
- 309
- Issue
- 7
- Pages
- C444-C456
- ISSN
- 0363-6143 (ISSN-L)
- 1522-1563
- OpenAlex
- W2276190994
- Cited by
- 377
- References
- 147
- FWCI
- 27.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.